Stay updated on SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Sign up to get notified when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.

Latest updates to the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page
- Check5 days agoChange DetectedThe page shows Revision: v3.3.4, replacing the prior Revision: v3.3.3. No study results or essential content appear to be altered.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedFooter now shows Revision: v3.3.3; the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check55 days agoChange DetectedThe site revision has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedRemoved the government funding/operating-status notice from the page.SummaryDifference0.2%

- Check76 days agoChange DetectedNo significant changes detected between versions; the page content and study results appear unchanged.SummaryDifference0.0%

- Check105 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference2%

Stay in the know with updates to SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.